(4R)-1-(2,3-dihydro-1H-inden-2-yl)-4-[(2-methyl-6-propylpyrimidin-4-yl)amino]pyrrolidin-2-one
C21H26N4O — CID 95727523
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-1-(2,3-dihydro-1H-inden-2-yl)-4-[(2-methyl-6-propylpyrimidin-4-yl)amino]pyrrolidin-2-one
(4R)-1-(2,3-dihydro-1H-inden-2-yl)-4-[(2-methyl-6-propylpyrimidin-4-yl)amino]pyrrolidin-2-one (PubChem CID 95727523) has the molecular formula C21H26N4O and a molecular weight of 350.47 g/mol. Its IUPAC name is (4R)-1-(2,3-dihydro-1H-inden-2-yl)-4-[(2-methyl-6-propylpyrimidin-4-yl)amino]pyrrolidin-2-one.
Molecular Properties
| Compound Name | (4R)-1-(2,3-dihydro-1H-inden-2-yl)-4-[(2-methyl-6-propylpyrimidin-4-yl)amino]pyrrolidin-2-one |
|---|---|
| PubChem CID | 95727523 |
| Molecular Formula | C21H26N4O |
| Molecular Weight | 350.47 g/mol |
| Exact Mass | 350.21 |
| IUPAC Name | (4R)-1-(2,3-dihydro-1H-inden-2-yl)-4-[(2-methyl-6-propylpyrimidin-4-yl)amino]pyrrolidin-2-one |
| SMILES | CCCc1cc(N[C@@H]2CC(=O)N(C3Cc4ccccc4C3)C2)nc(C)n1 |
| InChI | InChI=1S/C21H26N4O/c1-3-6-17-11-20(23-14(2)22-17)24-18-12-21(26)25(13-18)19-9-15-7-4-5-8-16(15)10-19/h4-5,7-8,11,18-19H,3,6,9-10,12-13H2,1-2H3,(H,22,23,24)/t18-/m1/s1 |
| InChIKey | OMSDUKKACKBHFR-GOSISDBHSA-N |
| XLogP | 2.92 |
| TPSA | 58.12 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 350.47 |
| LogP ≤ 5 | 2.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 95727523 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.